首頁 > 市場調查報告書 > 醫療設備

導管

市場調查報告書

商品編碼

1669742

2025 年靜脈 (IV) 補液療法全球市場報告

Intravenous (IV) Hydration Therapy Global Market Report 2025

出版日期: 2025年02月28日 | 出版商:

The Business Research Company | 英文 200 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄

預計未來幾年靜脈（IV）補液療法市場規模將強勁成長。到 2029 年，這一數字將成長至 44 億美元，複合年成長率為 9.6%。預測期內的成長可歸因於以消費者為中心的個人化、融入企業健康計畫、預防性保健措施、健身和健康旅遊的成長以及老齡化社會的需求。預測期內的主要趨勢包括關注道德和永續採購、整體健康、補水吧和休息室以及心理健康。

由於慢性病預計激增，靜脈（IV）補液療法市場預計將大幅成長。該治療方法包括靜脈注射維生素和必需營養素，為與慢性疾病作鬥爭的人提供顯著的能量提升。截至 2022 年 9 月，世界衛生組織 (WHO) 報告稱，每年死亡人數高達 4,100 萬人，佔全球非傳染性疾病 (NCD) 或慢性病死亡人數的 74%。其中，心血管疾病導致1,790萬人死亡，癌症造成930萬人死亡，慢性呼吸道疾病導致410萬人死亡，糖尿病導致200萬人死亡。此類慢性疾病的增加是推動靜脈（IV）補液療法市場成長的關鍵因素。

老齡人口的持續成長將進一步刺激靜脈（IV）補液療法市場的擴張。老齡化社會的特徵是老年人口比例不斷增加，可以有效依靠靜脈補液療法來對抗脫水和補充必需營養素，改善整體健康和福祉。根據世界衛生組織（WHO）2022年10月發布的預測，到2030年，全球每六人中就有一人年齡超過60歲。預計在此期間，60歲及以上人口比例將從2020年的10億增加到14億。此外，預計到 2050 年，全球 60 歲及以上人口將增加一倍，達到 21 億。因此，不斷成長的老化人口是靜脈 (IV) 補液療法市場的主要驅動力。

全球靜脈（IV）補液療法PESTEL分析（政治、社會、技術、環境、法律、促進因素、限制因素）
最終用途產業分析
全球靜脈（IV）補液療法市場：成長率分析
全球靜脈 (IV) 補液療法市場表現：規模與成長，2019-2024 年
全球靜脈補液療法市場預測：2024-2029 年及 2034 年規模與成長
全球靜脈 (IV) 補液療法總目標市場 (TAM)

第6章市場細分

全球靜脈 (IV) 補液療法市場（按服務、績效和預測），2019-2024 年、2024-2029 年、2034 年
免疫增強劑
能量增強劑
護膚
偏頭痛
其他服務
全球靜脈 (IV) 補液療法市場：按成分、績效和預測，2019-2024 年、2024-2029 年、2034 年
藥用
非藥品
全球靜脈 (IV) 補液療法市場（按最終用戶、績效和預測），2019-2024 年、2024-2029 年、2034 年
醫院和診所
健康中心和水療中心
家庭醫療保健
其他最終用戶
全球靜脈 (IV) 水合療法市場按免疫增強劑類型細分，實際及預測，2019-2024 年、2024-2029 年、2034 年
維生素C滴注
鋅輸注
麩胺基硫輸注
全球靜脈 (IV) 補水療法市場、能量增強劑細分市場、類型、績效及預測，2019-2024 年、2024-2029 年、2034 年
維生素B複合物輸注
胺基酸輸注
電解液
全球靜脈 (IV) 補液療法市場（按護膚、細分、績效和預測）2019-2024 年、2024-2029 年、2034 年
補水注射
抗衰老注射
排毒輸液
全球靜脈 (IV) 補液療法市場按偏頭痛類型細分，實際及預測，2019-2024 年、2024-2029 年、2034 年
止痛點滴
鎂灌注
補水注射
全球靜脈 (IV) 補液療法市場、其他服務細分、按類型、實際和預測，2019-2024 年、2024-2029 年、2034 年
解酒藥
減重點滴
運動表現注入

第7章區域和國家分析

全球靜脈 (IV) 補液療法市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
全球靜脈 (IV) 補液療法市場：按國家、表現和預測，2019-2024 年、2024-2029 年、2034 年

第8章亞太市場

第9章：中國市場

第10章印度市場

第11章日本市場

第12章澳洲市場

第13章印尼市場

第14章韓國市場

第15章西歐市場

第16章英國市場

第 17 章德國市場

第 18 章法國市場

第 19 章：義大利市場

第 20 章：西班牙市場

第21章東歐市場

第22章俄羅斯市場

第23章北美市場

第24章美國市場

第 25 章：加拿大市場

第26章南美洲市場

第 27 章：巴西市場

第28章中東市場

第 29 章：非洲市場

第 30 章競爭格局與公司概況

靜脈補液療法市場：競爭格局
靜脈（IV）補液療法市場：公司簡介
- Revitalist Overview, Products and Services, Strategy and Financial Analysis
- JW Life Science Corporation Overview, Products and Services, Strategy and Financial Analysis
- NextGen Healthcare Overview, Products and Services, Strategy and Financial Analysis
- Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- Fresenius Kabi AG Overview, Products and Services, Strategy and Financial Analysis

第31章其他大型創新企業

Liquid IV
Medtronic Plc.
Drip Hydration
Amanta Healthcare Ltd.
Becton Dickinson and Company
Elixir
Baxter International Inc.
Otsuka Pharmaceutical Co. Ltd.
Sippex IV bag
REVIV
Braun Melsungen AG
The IV Doc Inc.
Terumo Medical Corporation
Grifols SA
Harpal Clinic Ltd.

第 32 章全球市場競爭基準化分析與儀表板

第33章重大併購

第 34 章近期市場趨勢

第 35 章高市場潛力國家、細分市場與策略

靜脈 (IV) 補液療法市場 2029：提供新機會的國家
靜脈 (IV) 補液療法市場 2029：細分市場提供新機會
靜脈 (IV) 補液療法市場 2029：成長策略
- 基於市場趨勢的策略
- 競爭對手的策略

第 36 章附錄

簡介目錄

Product Code: r25046

Intravenous (IV) hydration therapy is a simple medical procedure involving the insertion of a small IV into the arm to deliver fluids directly into the bloodstream. This method facilitates faster absorption of nutrients, fluids, medications, and blood, aiding in the body's treatment and recovery process by utilizing the circulatory system.

The primary service categories within intravenous (IV) hydration therapy encompass immune boosters, energy boosters, skin care treatments, migraine relief, and other specialized therapies. Immunity boosters are products designed to enhance the immune system and reduce susceptibility to illnesses. These products come in medicated and non-medicated forms and cater to diverse end-users, including hospitals and clinics, wellness centers and spas, home healthcare services, and other relevant facilities.

The intravenous(IV) hydration therapy market research report is one of a series of new reports from The Business Research Company that provides intravenous(IV) hydration therapy market statistics, including intravenous(IV) hydration therapy industry global market size, regional shares, competitors with an intravenous(IV) hydration therapy market share, detailed intravenous(IV) hydration therapy market segments, market trends, and opportunities, and any further data you may need to thrive in the intravenous(IV) hydration therapy industry. This intravenous (IV) hydration therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The intravenous (IV) hydration therapy market size has grown strongly in recent years. It will grow from $2.82 billion in 2024 to $3.05 billion in 2025 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to medical treatments and procedures, athletic and sports performance, clinical management of dehydration, recovery from illnesses, and mobile and concierge services

The intravenous (IV) hydration therapy market size is expected to see strong growth in the next few years. It will grow to $4.4 billion in 2029 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to consumer-centric personalization, integration into corporate wellness programs, preventive health measures, growth in fitness and wellness tourism, and aging population demands. Major trends in the forecast period include ethical and sustainable sourcing, holistic health retreats, hydration bars and lounges, and a focus on mental wellness.

The anticipated surge in the prevalence of chronic diseases is poised to drive significant growth in the intravenous (IV) hydration therapy market. This therapeutic approach involves the administration of vitamins and essential nutrients intravenously, offering a substantial energy boost to individuals grappling with chronic diseases. As of September 2022, the World Health Organization reported a staggering 41 million annual deaths, accounting for 74% of fatalities attributed to non-communicable diseases (NCDs) or chronic ailments globally. Notably, cardiovascular diseases contributed to 17.9 million deaths, cancer to 9.3 million deaths, chronic respiratory diseases to 4.1 million deaths, and diabetes to 2.0 million deaths. This escalation in chronic disease prevalence is a pivotal factor propelling the growth of the intravenous (IV) hydration therapy market.

The continual rise in the aging population is poised to further fuel the expansion of the intravenous (IV) hydration therapy market. Characterized by an increasing proportion of elderly individuals in society, the aging population is effectively addressed by IV hydration therapy to combat dehydration and provide essential nutrients, thereby enhancing overall health and well-being. Projections from the World Health Organization in October 2022 indicated that, by 2030, one out of every six individuals globally would be 60 years old or older. The proportion of the population aged 60 and over is expected to rise from 1 billion in 2020 to 1.4 billion during this period. Furthermore, the global population of individuals aged 60 and older is anticipated to double, reaching 2.1 billion by 2050. Consequently, the increasing aging population stands as a significant driver for the intravenous (IV) hydration therapy market.

The intravenous (IV) hydration therapy market is experiencing a notable trend towards product innovation, with major companies leveraging new technologies to maintain their market positions. An illustrative example occurred in September 2022 when Concierge Medical Consultants Inc, a Canada-based group of board-certified physicians specializing in private, discreet, and personalized healthcare, introduced Intravenous Vitamin Therapy (IV Therapy) to its services in Toronto and Vancouver. This addition included a novel IV hydration service featuring six variations of Vitamindrip products such as hydration, recovery, energy, cosmetics, diet and detox, and immune boost. The scientifically formulated Vitamin drip, administered intravenously, effectively addresses dehydration and various disorders such as migraines, acute muscle spasms, asthma, upper respiratory tract infections, chronic sinusitis, and seasonal allergic rhinitis.

Major players in the intravenous (IV) hydration therapy market are directing their efforts towards the development of sterile solutions, particularly CBD isolate, to meet the growing demand for CBD infusion and gain a competitive edge. CBD isolate, recognized as the purest form of cannabidiol, contains no additional cannabinoids or plant compounds. In a notable development in September 2023, Apex Labs CBD, a US-based company offering a diverse range of high-quality CBD products, launched Pico IV, a CBD isolate specifically designed for intravenous (IV) therapy. Pico IV's sterile solution ensures safe intravenous use, catering to the increasing demand for CBD infusion in the rapidly expanding IV hydration therapy market. Distinguished by the reduction of the CBD molecule size to a picometer, Pico IV offers maximum absorption and is exclusively available for online purchase to licensed IV therapy providers.

In May 2022, Fresenius Kabi AG, a prominent healthcare company based in Germany, completed the acquisition of Ivenix Inc. The financial details of the transaction were undisclosed. This strategic move by Fresenius Kabi AG is aimed at establishing a comprehensive and innovative portfolio of top-tier infusion treatment solutions specifically tailored for the American market. Ivenix Inc., based in the United States, is recognized for pioneering a new generation of intravenous (IV) hydration therapy. The acquisition aligns with Fresenius Kabi AG's commitment to enhancing and diversifying its offerings in the healthcare sector, particularly in the realm of infusion treatments.

Major companies operating in the intravenous (IV) hydration therapy market include Revitalist, JW Life Science Corporation, NextGen Healthcare, Pfizer Inc., Fresenius Kabi AG, Liquid IV, Medtronic Plc., Drip Hydration, Amanta Healthcare Ltd., Becton Dickinson and Company, Elixir, Baxter International Inc., Otsuka Pharmaceutical Co. Ltd., Sippex IV bag, REVIV, Braun Melsungen AG, The IV Doc Inc., Terumo Medical Corporation, Grifols S.A., Harpal Clinic Ltd., Fosmo Med, Core IV Therapy LLC, Cryojuvenate UK Ltd., Hospira, Teleflex Incorporated, Sichuan Kelun Pharmaceutical Co.Ltd., ICU Medical Inc., Vygon SAS, Vifor Pharma Management AG

North America was the largest region in the intravenous (IV) hydration therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intravenous (iv) hydration therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the intravenous (iv) hydration therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The intravenous (IV) hydration therapy market includes revenues earned by entities by providing normal saline, half-normal saline, lactated ringers, dextrose, and related detoxification. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Intravenous (IV) Hydration Therapy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on intravenous (iv) hydration therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for intravenous (iv) hydration therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The intravenous (iv) hydration therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Service: Immune Boosters; Energy Boosters; Skin Care; Migraine; Other Service
2) By Component: Medicated; Non-Medicated
3) By End-User: Hospitals And Clinics; Wellness Centers And Spas; Home Healthcare; Other End-Users
Subsegments:
1) By Immune Boosters: Vitamin C Infusion; Zinc Infusion; Glutathione Infusion
2) By Energy Boosters: B-Complex Vitamins Infusion; Amino Acids Infusion; Electrolyte Solutions
3) By Skin Care: Hydration Infusion; Anti-Aging Infusion; Detox Infusion
4) By Migraine: Pain Relief Infusion; Magnesium Infusion; Hydration Infusion
5) By Other Services: Hangover Relief Infusion; Weight Loss Infusion; Athletic Performance Infusion
Companies Mentioned: Revitalist; JW Life Science Corporation; NextGen Healthcare; Pfizer Inc.; Fresenius Kabi AG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

1. Executive Summary

2. Intravenous (IV) Hydration Therapy Market Characteristics

3. Intravenous (IV) Hydration Therapy Market Trends And Strategies

4. Intravenous (IV) Hydration Therapy Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Intravenous (IV) Hydration Therapy Growth Analysis And Strategic Analysis Framework

5.1. Global Intravenous (IV) Hydration Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Intravenous (IV) Hydration Therapy Market Growth Rate Analysis
5.4. Global Intravenous (IV) Hydration Therapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Intravenous (IV) Hydration Therapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Intravenous (IV) Hydration Therapy Total Addressable Market (TAM)

6. Intravenous (IV) Hydration Therapy Market Segmentation

6.1. Global Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Immune Boosters
Energy Boosters
Skin Care
Migraine
Other Service
6.2. Global Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Medicated
Non-Medicated
6.3. Global Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals And Clinics
Wellness Centers And Spas
Home Healthcare
Other End-Users
6.4. Global Intravenous (IV) Hydration Therapy Market, Sub-Segmentation Of Immune Boosters, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Vitamin C Infusion
Zinc Infusion
Glutathione Infusion
6.5. Global Intravenous (IV) Hydration Therapy Market, Sub-Segmentation Of Energy Boosters, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
B-Complex Vitamins Infusion
Amino Acids Infusion
Electrolyte Solutions
6.6. Global Intravenous (IV) Hydration Therapy Market, Sub-Segmentation Of Skin Care, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hydration Infusion
Anti-Aging Infusion
Detox Infusion
6.7. Global Intravenous (IV) Hydration Therapy Market, Sub-Segmentation Of Migraine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pain Relief Infusion
Magnesium Infusion
Hydration Infusion
6.8. Global Intravenous (IV) Hydration Therapy Market, Sub-Segmentation Of Other Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hangover Relief Infusion
Weight Loss Infusion
Athletic Performance Infusion

7. Intravenous (IV) Hydration Therapy Market Regional And Country Analysis

7.1. Global Intravenous (IV) Hydration Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Intravenous (IV) Hydration Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Intravenous (IV) Hydration Therapy Market

8.1. Asia-Pacific Intravenous (IV) Hydration Therapy Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Intravenous (IV) Hydration Therapy Market

9.1. China Intravenous (IV) Hydration Therapy Market Overview
9.2. China Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Intravenous (IV) Hydration Therapy Market

10.1. India Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Intravenous (IV) Hydration Therapy Market

11.1. Japan Intravenous (IV) Hydration Therapy Market Overview
11.2. Japan Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Intravenous (IV) Hydration Therapy Market

12.1. Australia Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Intravenous (IV) Hydration Therapy Market

13.1. Indonesia Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Intravenous (IV) Hydration Therapy Market

14.1. South Korea Intravenous (IV) Hydration Therapy Market Overview
14.2. South Korea Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Intravenous (IV) Hydration Therapy Market

15.1. Western Europe Intravenous (IV) Hydration Therapy Market Overview
15.2. Western Europe Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Intravenous (IV) Hydration Therapy Market

16.1. UK Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Intravenous (IV) Hydration Therapy Market

17.1. Germany Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Intravenous (IV) Hydration Therapy Market

18.1. France Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Intravenous (IV) Hydration Therapy Market

19.1. Italy Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Intravenous (IV) Hydration Therapy Market

20.1. Spain Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Intravenous (IV) Hydration Therapy Market

21.1. Eastern Europe Intravenous (IV) Hydration Therapy Market Overview
21.2. Eastern Europe Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Intravenous (IV) Hydration Therapy Market

22.1. Russia Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Intravenous (IV) Hydration Therapy Market

23.1. North America Intravenous (IV) Hydration Therapy Market Overview
23.2. North America Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Intravenous (IV) Hydration Therapy Market

24.1. USA Intravenous (IV) Hydration Therapy Market Overview
24.2. USA Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Intravenous (IV) Hydration Therapy Market

25.1. Canada Intravenous (IV) Hydration Therapy Market Overview
25.2. Canada Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Intravenous (IV) Hydration Therapy Market

26.1. South America Intravenous (IV) Hydration Therapy Market Overview
26.2. South America Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Intravenous (IV) Hydration Therapy Market

27.1. Brazil Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Intravenous (IV) Hydration Therapy Market

28.1. Middle East Intravenous (IV) Hydration Therapy Market Overview
28.2. Middle East Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Intravenous (IV) Hydration Therapy Market

29.1. Africa Intravenous (IV) Hydration Therapy Market Overview
29.2. Africa Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Intravenous (IV) Hydration Therapy Market Competitive Landscape And Company Profiles

30.1. Intravenous (IV) Hydration Therapy Market Competitive Landscape
30.2. Intravenous (IV) Hydration Therapy Market Company Profiles
- 30.2.1. Revitalist Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. JW Life Science Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. NextGen Healthcare Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Fresenius Kabi AG Overview, Products and Services, Strategy and Financial Analysis

31. Intravenous (IV) Hydration Therapy Market Other Major And Innovative Companies

31.1. Liquid IV
31.2. Medtronic Plc.
31.3. Drip Hydration
31.4. Amanta Healthcare Ltd.
31.5. Becton Dickinson and Company
31.6. Elixir
31.7. Baxter International Inc.
31.8. Otsuka Pharmaceutical Co. Ltd.
31.9. Sippex IV bag
31.10. REVIV
31.11. Braun Melsungen AG
31.12. The IV Doc Inc.
31.13. Terumo Medical Corporation
31.14. Grifols S.A.
31.15. Harpal Clinic Ltd.

32. Global Intravenous (IV) Hydration Therapy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Intravenous (IV) Hydration Therapy Market

34. Recent Developments In The Intravenous (IV) Hydration Therapy Market

35. Intravenous (IV) Hydration Therapy Market High Potential Countries, Segments and Strategies

35.1 Intravenous (IV) Hydration Therapy Market In 2029 - Countries Offering Most New Opportunities
35.2 Intravenous (IV) Hydration Therapy Market In 2029 - Segments Offering Most New Opportunities
35.3 Intravenous (IV) Hydration Therapy Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies